MedPro Safety Products — Investor Presentation (May 2011)
21 slides from MedPro Safety Products's investor presentation, May 4, 2011
Slide 1: MedPro (OTCBB:MPSP)
Slide 2: Forward-looking statements
This release includes forward-looking statements based upon current expectations of the management of MedPro Safety Products, Inc. that involve risks and uncertainties, such as plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those
Slide 3: More than 1 million needlesticks annually
More than 1 million needlesticks annually Each needlestick costs approximately $3,000 Current solutions do not fully address problem
Slide 4: Bloodborne pathogens
Hepatitis C Hepatitis B HIV Bloodborne Pathogen Microorganisms present in human blood that can cause disease in humans Over 20 OSHA others
Slide 5: OSHA, CDC, FDA require safety-engineered sharps; four market segments
OSHA, CDC, FDA require employers and providers to evaluate sharps with engineered sharps injury protections (SESIPs) across major device categories; such as safety syringes, blood collection devices, IV catheters, etc. Infection Control Today, 2009 Four Market Segments Market Opportunities Phlebotom
Slide 6: Current safety mechanisms: slide, snap, retractable
Slide The user slides a guard over the needle Snap The user snaps a guard over the needle Retractable The user activates the retraction of the needle
Slide 7: The Future of Safety: passive safety features
“A passive safety feature is one that requires no action by the user.” “Today, there are very few safety-engineered medical devices that require no active step to make a device safer during use, after use and prior to disposal.” Centers for Disease Control Infection Control Today, 2009 The Future of
Slide 8: Vacuette Premium Blood Collection
Vacuette® Premium Blood Collection
Slide 9: IV Winged Collection Set
IV Winged Collection Set
Slide 10: Demonstration of MedPro blood collection products versus market leaders
Demonstration of operation of MedPro blood collection products compared to current market leading products
Slide 11: Prefilled Drug Delivery System
Prefilled Drug Delivery System
Slide 12: Clinical Hypodermic Safety Syringe
Clinical Hypodermic Safety Syringe
Slide 13: Patent and application portfolio by product
Application, Product Application Patent/Publication Title Publication or Issue Reference Number Number Date Needleless IV medical Key-Lok 09/136,478 6,146,362 11/14/2000 delivery system Automatic non-Vacu-Mate 08/632,010 5,688,241 reusable needle 11/18/1997 guard Protection device for Vacu-Mate 09/3
Slide 14: Market segments and contractual partners
Market Segment Phlebotomy Contractual Partners Targeted Networks Pharma Others Infusion Clinical
Slide 15: Expected revenue generation by product
Product Expected Revenue Generation Tube Touch 2011 Skin Touch 2012 Wing 2012 Fillable 2012 Prefilled 2013
Slide 16: Revenue generation began Q1 2011
Revenue generation began Q1 2011 Guaranteed revenue totals $44 million through 2016 Completed $30 million Senior Notes offering (securitized by blood collection revenues) Current run rate = 2 years cash Strong 5 year profitability potential
Slide 17: Revenue projections 2011-2016
160 145 Millions 140 120 in Projections 100 77 Prefilled 80 Fillable 60 Blood Collection 38.6 Revenue 40 19.5 20 3.5 8 0 2011 2012 2013 2014 2015 2016
Slide 18: Management team
Craig Turner › MedPro Founder, CEO and Chairman of the Board › 15 years needle technology experience; Acquired 8 passive needle technologies Walter Weller › President since 2003 › Experienced financial and operational manager Greg Schupp › COO with 20 years manufacturing and medical technology exper
Slide 19: Board of directors
Craig Turner, Chairman Ernie Fletcher, Director Leo Kiely, Director Carl Kleidman, Director Gary Peterson, Director Warren Rustand, Director Walter Weller, Director
Slide 20: MedPro Safety Products solutions
Healthcare industry experts estimate healthcare workers are routinely stuck one million times annually from exposed needles. MedPro Safety Products Inc. has solutions that virtually eliminate the risk of serious bloodborne diseases during the use of “sharps” devices. Our ergonomic, automatic, patent
Slide 21: Addressing $3 billion market opportunity
Addressing $3 Billion Market Opportunity Strategic Partnerships with Industry Leaders Strong Product Pipeline Unique IP Portfolio Proven Management Team
MedPro Safety Products — Investor Presentation (May 2011) on 6ix